Senate Republicans Aim to Postpone Trump’s Science Funding Strategy

2 days ago 0

Senate Republicans have incorporated a clause in the stopgap funding bill aimed at delaying the Trump administration’s plan to allow political appointees to manage vast amounts of federal grant money. This action marks a rare dissent from congressional Republicans against the administration’s approach.

The government funding measure is temporary, extending only until December 11. After this date, the contested rule may still come into effect. The Office of Management and Budget’s proposition faced widespread criticism, drawing nearly 500,000 comments with the vast majority expressing disapproval.

If finalized, this rule would enable grant-awarding offices to terminate federal grants without specific cause. Additionally, it would transform uniform guidance into binding regulations, limiting the agency’s flexibility. Cole Donovan, policy director for the advocacy group Stand Up for Science, highlighted concerns that involving political appointees would decrease accountability and transparency in grant review processes.

“When you have grant review processes that are subject to the arbitrary decision of a political appointee, that inherently means there’s less accountability on the agency side, and less transparency into how decisions are made,” said Donovan.

Appropriations Committee Chair Susan Collins (R-Maine) has advocated for reversing parts of the rule. She expressed satisfaction that the provision made it into the spending bill, citing fears that the rule could politicize grants and negatively impact small rural communities, families, and biomedical research.

Senator Patty Murray (D-Wash.), who collaborated with Collins on the provision, attempted to permanently abolish the proposal but faced opposition from Republicans. “Enabling this rule would only give Trump the greenlight to take even more federal funding hostage,” Murray stated. She remains committed to stopping the proposal and urges her Republican counterparts to join her efforts.

Welcome to The Hill’s Healthcare newsletter with Nathaniel Weixel and Joseph Choi. Every week, we keep you updated on how political decisions affect healthcare.

In recent news, Health and Human Services Secretary Robert F. Kennedy Jr. has publicly supported the measles vaccine but also spread unfounded claims regarding other vaccines and related health emergencies. In response, a class-action lawsuit was filed by the Human Rights Campaign against the Trump administration’s ban on gender-affirming care in federal workers’ health insurance plans, alleging a violation of federal sex discrimination prohibitions.

Additionally, Michigan’s Department of Health and Human Services reported two deaths linked to cyclosporiasis, noting both individuals had significant underlying health issues. The state has documented over 11,200 cases of this illness, characterized by severe diarrhea and loss of appetite.

In upcoming events, the Senate Budget Committee will discuss Medicaid’s current status, while the Senate Finance Subcommittee on Health Care explores biotechnology’s role in building a robust healthcare future.

In related news, President Trump criticized U.S. Attorney Jeanine Pirro’s handling of charges against Olympian David Hearn, and around the nation, Virginia hemp businesses challenge new THC product limits, while Missouri observes an increase in mail-ordered abortion pills from out-of-state.

Highlighted news includes Eli Lilly’s expanded access program for an unapproved obesity drug, and significant donations to restore some global health aid by the State Department.